NSE filing, NSE: AAVAS. Summary written from the filing by ALFA Finder's alert engine.
Aavas Financiers Ltd: key numbers
- Share price
- ₹1,107.20
- Market cap
- ₹8,780 Cr
- Revenue (annual)
- ₹2,683 Cr
- Net profit (annual)
- ₹654.9 Cr
- P/E (TTM)
- 12.5×Sector 19.7×
- Promoter holding
- 48.88%+0.00% QoQ
- FII holding
- 15.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aavas Financiers Ltd
All →Aavas Financiers Debt & Borrowing: ₹22.3 Cr
Aavas Financiers certified timely half-yearly interest payment of ₹22.30 Crore on its NCDs (ISIN INE216P07241). No redemption payment was made during the period.
- Value
- ₹22.30 Cr
Aavas Financiers Regulatory Approval
AAVAS Financiers received an IRDAI Certificate of Registration to act as a Corporate Agent, effective December 8, 2026, and perpetual subject to annual fees. The approval lets the company solicit insurance products to its customers.
- Execution
- Valid from December 08, 2026; perpetual subject to annual fee and compliance
Aavas Financiers Management Change
AAVAS Financiers accepted the resignation of Independent Director Soumya Rajan and HIA Ramachandran Venkatesh, and appointed Anjali Seth as Independent Director and Bharat Thakkar as HIA. A postal ballot for Seth's appointment was also approved.
Aavas Financiers Results Update
AAVAS Financiers released H1FY27 investor highlights, with net profit up 16.4% YoY to ₹3.5 billion. Figures come from a press release, not a full results statement.
Aavas Financiers Investor Presentation: Key Takeaways
H1FY27 PAT ₹3,528mn (+16.4% YoY); Q2FY27 PAT ₹1,815mn (+10.7% YoY). AUM ₹248bn (+16%), Q2 NIM 7.81%. Focus on 20% AUM growth.
Aavas Financiers Q2 FY27 Results: Net Profit ₹181.5 Cr, Up 10.7% YoY
Aavas Financiers Ltd reported revenue from operations of ₹736.3 Cr (+10.4% YoY) and net profit of ₹181.5 Cr (+10.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹181.5 Cr · +10.7% YoY
Other employee stock options announcements
All →Borosil Employee Stock Options
Borosil granted 7,23,200 employee stock options at Rs 192.8 each under its 2020 scheme. Options vest in three tranches over three years.
- Execution
- Vesting over 3 years from grant date
Natco Pharma Employee Stock Options
Natco Pharma's insiders, including promoters and directors, were allotted equity shares. This allotment increases their total shareholding in the company.
- Value
- ₹144.2 Cr
Coforge Employee Stock Options
Coforge allotted 24,242 equity shares under its ESOP (2005) scheme on 29 October 2026. Paid-up capital rises to 44,30,62,864 equity shares.
Greenply Industries Employee Stock Options
Greenply Industries allotted 500 equity shares under its ESOP 2020 scheme on 29 October 2026. The allotment lifts paid-up capital to Rs.12,49,02,545.
Firstsource Solutions Employee Stock Options
Firstsource's Nomination and Remuneration Committee approved a grant of 587,750 stock options to eligible employees. The grant falls under its 2019 Employee Stock Option Plan.
Vedanta Power Employee Stock Options
Vedanta Power granted 78,11,356 ESOP stock options under VPL ESOP 2026 to eligible employees including KMP. Options vest over 36 months at an exercise price of Rs 10 per share.
- Execution
- 36 months vesting from grant date; exercisable within 8 months of vesting